WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS

B02A ANTIFIBRINOLYTICS

This group comprises agents, which inhibit fibrinolytic activity.
Combinations with vitamin K, see B02B - Vitamin K and other hemostatics.

The DDDs are based on treatment of hemorrhage associated with fibrinolysis.

B02B VITAMIN K AND OTHER HEMOSTATICS

The DDDs are based on treatment of hemorrhage associated with different deficiency states (e.g. vitamin K deficiency, deficiency of different blood coagulation factors etc.).

Last updated: 2024-01-26